Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 7, 2013
Event: Regulation FD Disclosure regarding a proposed public offering of common stock.
Key Financial Metrics
This filing does not report historical financial performance metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial figure disclosed is the proposed capital raise:
- Proposed Offering Size: $50,000,000
- Security Type: Common Stock
- Underwriters: Jefferies LLC (Sole Book-Running Manager) and Noble Financial Capital Markets (Co-Manager)
Material Changes
The filing announces a material change in the company's capital structure plans. On March 7, 2013, the Company issued a press release stating its intent to offer and sell $50,000,000 of common stock in an underwritten public offering, subject to market and other conditions.
Guidance, Outlook, and Risks
Outlook and Conditions:
- There is no assurance as to whether or when the Offering may be completed.
- There is no assurance regarding the actual size or terms of the Offering.
- The Offering is subject to market conditions and customary closing conditions.
- Forward-looking statements are subject to risks including market conditions and the satisfaction of closing conditions.
- General business and financial risks are referenced in the Company's Form 10-K (filed March 27, 2012) and Form 8-K (filed January 25, 2013).
- The Company undertakes no obligation to revise or update forward-looking statements.
Investor Verification Checklist
- Verify the final completion status of the $50,000,000 proposed offering.
- Confirm the actual number of shares issued and the final offering price once the transaction closes.
- Review the Company's Form 10-K (March 27, 2012) and Form 8-K (January 25, 2013) for detailed risk factors and historical financial context.
- Monitor subsequent filings for updates on the satisfaction of closing conditions.